Protein expression of luminal (CK20, GATA3, ERβ, Her2) and basal (CK5/6, CK14) markers as well as of p53 was evaluated in 156 CIS specimens from 132 patients (104 men and 28 women) using IHC. This evidence concerns the gene KRT5 and in situ carcinoma.